Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Oragenics Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 13 | 0 |
| Shares | 52.5K | 61.4K | +8.90K (+17.0%) |
| Value | $173.5K | $182.1K | +$8.64K (+5.0%) |
New holders (1)
Institutions that held Oragenics Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Team Financial Group, LLC | 1 | $3 | 0.00% |
Sold out (1)
Institutions that held Oragenics Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Northwestern Mutual Wealth Management Co | 35 | $116 |